Martin J. Cannon

5.9k total citations
115 papers, 4.6k citations indexed

About

Martin J. Cannon is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Martin J. Cannon has authored 115 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Immunology, 41 papers in Oncology and 27 papers in Epidemiology. Recurrent topics in Martin J. Cannon's work include Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (38 papers) and T-cell and B-cell Immunology (20 papers). Martin J. Cannon is often cited by papers focused on Immunotherapy and Immune Responses (50 papers), Immune Cell Function and Interaction (38 papers) and T-cell and B-cell Immunology (20 papers). Martin J. Cannon collaborates with scholars based in United States, Italy and United Kingdom. Martin J. Cannon's co-authors include Alessandro D. Santin, Sërgio Pecorelli, B A Askonas, Stefania Bellone, Peter Openshaw, Juan J. Roman, Antonella Ravaggi, Groesbeck P. Parham, Michela Palmieri and Paul L. Hermonat and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Martin J. Cannon

114 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin J. Cannon United States 39 2.0k 1.4k 1.4k 997 451 115 4.6k
Elisabeth H. Weiss Germany 44 3.9k 1.9× 549 0.4× 724 0.5× 1.4k 1.4× 205 0.5× 133 5.9k
Megan A. Cooper United States 32 8.8k 4.3× 2.5k 1.8× 960 0.7× 808 0.8× 306 0.7× 84 10.0k
Jacqueline Feinberg France 28 1.8k 0.9× 436 0.3× 752 0.5× 576 0.6× 580 1.3× 74 2.9k
Philippe Delvenne Belgium 44 1.7k 0.8× 1.6k 1.1× 1.3k 1.0× 1.8k 1.8× 94 0.2× 175 5.4k
W Wiktor-Jędrzejczak Poland 30 1.9k 0.9× 1.5k 1.1× 284 0.2× 2.0k 2.0× 357 0.8× 222 5.5k
Niklas K. Björkström Sweden 42 4.4k 2.1× 996 0.7× 1.5k 1.1× 433 0.4× 647 1.4× 118 6.1k
Peter Ebbesen Denmark 35 1.1k 0.5× 649 0.5× 854 0.6× 1.3k 1.3× 790 1.8× 222 4.5k
Jakob Michaëlsson Sweden 43 5.9k 2.9× 972 0.7× 1.0k 0.7× 769 0.8× 576 1.3× 79 7.3k
Shie‐Liang Hsieh Taiwan 37 1.9k 0.9× 505 0.4× 576 0.4× 1.9k 1.9× 752 1.7× 109 5.3k
Yenan T. Bryceson Sweden 47 7.6k 3.7× 2.2k 1.5× 852 0.6× 1.1k 1.1× 728 1.6× 138 9.1k

Countries citing papers authored by Martin J. Cannon

Since Specialization
Citations

This map shows the geographic impact of Martin J. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin J. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin J. Cannon more than expected).

Fields of papers citing papers by Martin J. Cannon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin J. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin J. Cannon. The network helps show where Martin J. Cannon may publish in the future.

Co-authorship network of co-authors of Martin J. Cannon

This figure shows the co-authorship network connecting the top 25 collaborators of Martin J. Cannon. A scholar is included among the top collaborators of Martin J. Cannon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin J. Cannon. Martin J. Cannon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tesfay, Mulu Z., Alicja Urbaniak, Jean Christopher Chamcheu, et al.. (2024). Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines. 12(7). 1596–1596. 2 indexed citations
2.
Boehme, Karl W., et al.. (2020). Building Up While Shutting Down: An Academic Health System Educational Response to the COVID-19 Pandemic. MedEdPublish. 9. 165–165. 3 indexed citations
3.
Jenkins, Samir V., Michael S. Robeson, Robert J. Griffin, et al.. (2019). Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking. Cancer Research. 79(23). 5999–6009. 27 indexed citations
4.
Lamichhane, Purushottam, Lavakumar Karyampudi, Barath Shreeder, et al.. (2017). IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer. Cancer Research. 77(23). 6667–6678. 122 indexed citations
5.
Mirandola, Leonardo, Yuefei Yu, Martin J. Cannon, et al.. (2014). Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer. Gynecologic Oncology. 135(3). 573–579. 42 indexed citations
6.
Chiriva‐Internati, Maurizio, Yuefei Yu, Leonardo Mirandola, et al.. (2011). Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. The Prostate. 72(1). 12–23. 40 indexed citations
7.
Chiriva‐Internati, Maurizio, Leonardo Mirandola, Yuefei Yu, et al.. (2011). Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy. Journal of Immunotherapy. 34(6). 490–499. 18 indexed citations
8.
Chiriva‐Internati, Maurizio, Yuefei Yu, Leonardo Mirandola, et al.. (2010). Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer. PLoS ONE. 5(5). e10471–e10471. 41 indexed citations
9.
Yu, Yuefei, Wei Zhou, Nicoletta Gagliano, et al.. (2008). rAAV/Her-2/neu Loading of Dendritic Cells for a Potent Cellular-Mediated MHC Class I Restricted Immune Response Against Ovarian Cancer. Viral Immunology. 21(4). 435–442. 16 indexed citations
10.
Cannon, Martin J.. (2006). First Nations Citizenship: An Act to Amend the Indian Act (1985) and the Accomodation of Sex Discriminatory Policy. 3 indexed citations
11.
Bellone, Stefania, Stefania Canè, Michela Palmieri, et al.. (2005). High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer. Gynecologic Oncology. 98(1). 92–98. 58 indexed citations
12.
Canè, Stefania, Eliana Bignotti, Stefania Bellone, et al.. (2004). The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer. American Journal of Obstetrics and Gynecology. 190(1). 60–66. 35 indexed citations
13.
Santin, Alessandro D., Stefania Bellone, Stefania Canè, et al.. (2004). 006 Gene Expression Fingerprint of Uterine Serous Papillary Carcinoma: Identification of Novel Molecular Markers for Uterine Serous Cancer Diagnosis and Therapy. International Journal of Gynecological Cancer. 14. 2–2. 5 indexed citations
14.
Khanolkar, Aaruni, et al.. (2003). CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells. The Journal of Immunology. 170(6). 3187–3194. 5 indexed citations
15.
Bellone, Stefania, Michela Palmieri, Murat Gökden, et al.. (2003). Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy. Gynecologic Oncology. 91(1). 231–240. 29 indexed citations
16.
Santin, Alessandro D., Stefania Bellone, Murat Gökden, et al.. (2002). Overexpression of HER-2/neu in uterine serous papillary cancer.. PubMed. 8(5). 1271–9. 143 indexed citations
17.
Cannon, Martin J., Timothy J. O’Brien, Lowell J. Underwood, et al.. (2002). Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer. Expert Review of Anticancer Therapy. 2(1). 97–105. 19 indexed citations
18.
Santin, Alessandro D., Paul L. Hermonat, Antonella Ravaggi, et al.. (2000). Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 48(4). 997–1006. 86 indexed citations
19.
Rochford, Rosemary, Martin J. Cannon, Rebecca Sabbe, et al.. (1997). Common and Idiosyncratic Patterns of Cytokine Gene Expression by Epstein-Barr Virus Transformed Human B Cell Lines. Viral Immunology. 10(4). 183–195. 40 indexed citations
20.
Cannon, Martin J. & Peter H. Russell. (1988). Specificity of chicken secondaryin vitrolymphoproliferative responses to a parakeet isolate of avian paramyxovirus‐3. Avian Pathology. 17(2). 501–508. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026